Acknowledgments
George A., Tomas, Dent Neurologic Institute
RARE DISEASE
The authors would like to thank the patients, their families, and caregivers for participating in the study. We also acknowledge and thank the study coordinators and the investigators from the study sites. The ASCEND MG coinvestigators are: Laurence Adams, MD (Colorado Springs Neurological Associates, Colorado Springs, CO), Angela Genge, MD, FRCP (Montreal Neurological Institute and Hospital, Montreal, Canada), Ali Habib, MD (University of California Irvine, Orange, CA), John L. Hinton Jr., MD (Diagnostic and Medical Clinic, Mobile, AL), Tomas H. Holmlund, MD (Dent Neurologic Institute, Amherst, NY), Daniel H. Jacobs, MD (Neurological Services of Orlando P.A., Orlando, FL), Dale J. Lange, MD (Hospital for Special Surgery, New York, NY), Michael W. Nicolle, MD, FRCPC, DPhil (London Health Sciences Centre, London, Canada), Han C. Phan, MD (Rare Disease Research, LLC, Atlanta, GA), Nicholas J. Silvestri, MD, FAAN (University of Buffalo, Buffalo, NY), George A. Small, MD (Allegheny Neurological Associates, Pittsburgh, PA), Sharon Yegiaian, MD (Care Access Research, Pasadena, CA). We acknowledge Jennifer Schwinn, RPh, and Paola Mina‐Osorio, MD, PhD, employees of Immunovant, Inc., for their support in the organization and coordination of the manuscript. This study was funded by Immunovant Sciences GmbH.